Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 4:23 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1681–1704 of 17,755 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Population Clear all

Conditions: Posttraumatic Stress Disorder
Interventions: Yoga; Behavioral
Lead sponsor: Justice Resource Institute; Other
Eligibility: 18 Years to 58 Years · Female only
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Brookline, Massachusetts

Conditions: HIV/AIDS
Interventions: Wise App with medication adherence reminders, CHW Sessions; Device · Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Anaemia
Interventions: GSK1278863, Placebo, rhEPO; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 216 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 17
States / cities: Azusa, California • Los Angeles, California • San Dimas, California + 13 more

Conditions: SARS-CoV-2
Interventions: mRNA-1273, Placebo, mRNA-1273.214; Biological
Lead sponsor: ModernaTX, Inc.; Industry
Eligibility: 6 Months to 11 Years
Enrollment: 11,942 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 83
States / cities: Birmingham, Alabama • Phoenix, Arizona • Anaheim, California + 68 more

Conditions: Pain
Interventions: Non-visual immersive technology-based audio biofeedback intervention, Control (No non-visual immersive technology-based audio biofeedback); Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Lung Cancer
Interventions: Physical activity plus positive affect, Physical activity plus education; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 110 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Perennial Allergic Rhinitis, PAR
Interventions: Ciclesonide nasal aerosol 37 mcg, ciclesonide nasal aerosol 74 mcg, Placebo; Drug
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Eligibility: 6 Years to 11 Years
Enrollment: 848 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 60
States / cities: Hot Springs, Arkansas • Little Rock, Arkansas • Costa Mesa, California + 51 more

Conditions: FSGS, Focal Segmental Glomerulosclerosis, Glomerulosclerosis
Interventions: Placebo, CCX140-B; Other · Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 9
States / cities: Phoenix, Arizona • Torrance, California • Shreveport, Louisiana + 6 more

Conditions: Substance Abuse, Substance Addiction, Substance Use Disorder (SUD), Substance Use (Drugs, Alcohol), Human Immunodeficiency Virus (HIV)
Interventions: The TLC Program; Behavioral
Lead sponsor: Illinois Institute of Technology; Other
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Seriously Ill Hospitalized Patients
Interventions: Default Order, Accountable Justification, Standardized Usual Care; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 78,302 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 2
States / cities: Pasadena, California • Livonia, Michigan

Conditions: Heart Failure
Interventions: Sensor-controlled digital game (SCDG), Sensor Only; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 45 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Shoulder
Interventions: Methylprednisolone taper; Drug
Lead sponsor: The Hawkins Foundation; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Kidney Stone
Interventions: Norco 5milligram-325milligram Tablet, Ibuprofen 400 MILLIGRAM in 1 TABLET ORAL TABLET, FILM COATED; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Spinal Cord Injury
Interventions: Indego Powered Exoskeleton; Device
Lead sponsor: Parker Hannifin Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 3
States / cities: Port Jefferson, New York • Houston, Texas • Mechanicsville, Virginia

Conditions: Dental Anxiety, Dental Pain, Drug Use, Opioid Use
Interventions: Comfort Talk® app, White Noise app; Other
Lead sponsor: Hypnalgesics, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 2
States / cities: Boston, Massachusetts • Brookline, Massachusetts

Conditions: GERD
Interventions: Diaphragm Training; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Overactive Bladder
Interventions: fesoterodine fumarate, placebo, tolterodine tartrate; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 1,712 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 41
States / cities: Homewood, Alabama • Huntsville, Alabama • Mobile, Alabama + 36 more

Conditions: Obesity, Hypertension
Interventions: Lifestyle Modification Program, Usual Care and Reading Materials; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 21 Years and older
Enrollment: 365 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity
Interventions: Calorie-counting, MyPlate; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 261 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Long Beach, California • Los Angeles, California

Conditions: Sleep, Parenting, Eating Behavior, Obesity
Interventions: Baby Sleep, Baby Care; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Tobacco Use, Parental Smoking
Interventions: Telephone Quitline Enrollment; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: Not listed
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Pediatric ALL, Concussion, Mild, Concussion, Brain, Concussion, Intermediate
Interventions: Active Rehabilitation Group/Case; Behavioral
Lead sponsor: Children's National Research Institute; Other
Eligibility: 8 Years to 18 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Opioid Use Disorder, Opioid Abuse and Addiction, Narcotic-Related Disorders, Substance-Related Disorders, Chemically-Induced Disorders, Mental Disorder, Opioid
Interventions: Semaglutide Pen Injector, Placebo; Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 4
States / cities: Baltimore, Maryland • Fall River, Massachusetts • New York, New York + 1 more

Conditions: Condylomata Acuminata
Interventions: Polyphenon E Ointment 10%, Polyphenon E Ointment 15%; Drug
Lead sponsor: MediGene; Industry
Eligibility: 18 Years and older
Enrollment: 480 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 6
States / cities: Davis, San Diego, California • Denver, Colorado • New York, New York + 3 more

Search by objective public record fields.

Efficacy of Yoga for Treatment-Resistant Posttraumatic Stress Disorder

Community Health Worker And MHealth to ImProve Viral Suppression (CHAMPS Pilot)

Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia

A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age

IceBath: NOICE vs Nothing

Strides for Life I: Increasing Physical Activity in Stage 1 Lung Cancer Patients

A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).

A Study of CCX140-B in Subjects With FSGS

The Trans-Led Care Study

Comparing Optimized Models of Primary And Specialist Services for Palliative Care

Sensor-controlled Digital Game for Heart Failure Self-management: A Clinical Trial

Methylprednisolone Taper is an Effective Addition to Multimodal Pain Regimens After Rotator Cuff Repair

Opioid Free Management After Ureteroscopy

Indego Exoskeleton After SCI

Nonpharmacologic Reduction of Periprocedural Distress and Drug Use

Effectiveness of Diaphragmatic Breathing on Reflux Symptoms in Outpatients

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)

Evaluating a Blood Pressure Reduction and Weight Loss Program in a Low Income, Ethnically Diverse Population (The Be Fit, Be Well [BFBW] Study)

Is MyPlate Approach to Helping Overweight Patients Lose Weight More Patient-centered?

The Baby Care Study

An Intervention to Address Parental Smoking During the Postpartum Hospitalization.

Concussion Active Rehabilitation

GLP-1R Agonist Treatment for Opioid Use Disorder

Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts